Total properties:
15
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15064195
|
Filing Dt:
|
03/08/2016
|
Publication #:
|
|
Pub Dt:
|
09/15/2016
| | | | |
Title:
|
METHODS OF REDUCING SERUM LEVELS OF FC-CONTAINING AGENTS USING FCRN ANTAGONISTS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16011342
|
Filing Dt:
|
06/18/2018
|
Publication #:
|
|
Pub Dt:
|
04/11/2019
| | | | |
Title:
|
TREATMENT FOR ACUTE MYELOID LEUKEMIA WITH ANTI-CD70 ANTIBODIES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16213422
|
Filing Dt:
|
12/07/2018
|
Publication #:
|
|
Pub Dt:
|
06/27/2019
| | | | |
Title:
|
USE OF FCRN ANTAGONISTS FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16230326
|
Filing Dt:
|
12/21/2018
|
Publication #:
|
|
Pub Dt:
|
07/18/2019
| | | | |
Title:
|
BISPECIFIC ANTIGEN BINDING CONSTRUCT
|
|
|
Patent #:
|
|
Issue Dt:
|
12/20/2022
|
Application #:
|
16249480
|
Filing Dt:
|
01/16/2019
|
Publication #:
|
|
Pub Dt:
|
08/08/2019
| | | | |
Title:
|
CD70 COMBINATION THERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
09/06/2022
|
Application #:
|
16278522
|
Filing Dt:
|
02/18/2019
|
Publication #:
|
|
Pub Dt:
|
09/05/2019
| | | | |
Title:
|
ANTIBODIES TO CD70
|
|
|
Patent #:
|
|
Issue Dt:
|
10/25/2022
|
Application #:
|
16337815
|
Filing Dt:
|
03/28/2019
|
Publication #:
|
|
Pub Dt:
|
07/25/2019
| | | | |
Title:
|
TRIPLE VECTOR FOR EXPRESSING ANTIBODY MOLECULES IN FULL THERAPEUTIC FORMAT
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16435166
|
Filing Dt:
|
06/07/2019
|
Publication #:
|
|
Pub Dt:
|
01/23/2020
| | | | |
Title:
|
COMPOSITIONS AND METHODS FOR TREATING IMMUNE THROMBOCYTOPENIA
|
|
|
Patent #:
|
|
Issue Dt:
|
05/16/2023
|
Application #:
|
16599883
|
Filing Dt:
|
10/11/2019
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
Title:
|
ASYMMETRIC MULTISPECIFIC ANTIBODIES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16606656
|
Filing Dt:
|
10/18/2019
|
Publication #:
|
|
Pub Dt:
|
06/09/2022
| | | | |
Title:
|
METHOD OF PREPARING pH-DEPENDENT ANTIBODIES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/01/2023
|
Application #:
|
16719220
|
Filing Dt:
|
12/18/2019
|
Publication #:
|
|
Pub Dt:
|
07/16/2020
| | | | |
Title:
|
CD70 COMBINATION THERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
02/28/2023
|
Application #:
|
16893863
|
Filing Dt:
|
06/05/2020
|
Publication #:
|
|
Pub Dt:
|
12/24/2020
| | | | |
Title:
|
PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION
|
|
|
Patent #:
|
|
Issue Dt:
|
11/28/2023
|
Application #:
|
17398080
|
Filing Dt:
|
08/10/2021
|
Publication #:
|
|
Pub Dt:
|
03/10/2022
| | | | |
Title:
|
IL-6 BINDING MOLECULES
|
|
|
Patent #:
|
|
Issue Dt:
|
02/28/2023
|
Application #:
|
17491656
|
Filing Dt:
|
10/01/2021
|
Publication #:
|
|
Pub Dt:
|
04/21/2022
| | | | |
Title:
|
ANTIBODIES TO HUMAN COMPLEMENT C2B
|
|
|
Patent #:
|
|
Issue Dt:
|
07/25/2023
|
Application #:
|
17572518
|
Filing Dt:
|
01/10/2022
|
Publication #:
|
|
Pub Dt:
|
08/25/2022
| | | | |
Title:
|
ANTIBODIES TO HUMAN COMPLEMENT FACTOR C2B AND METHODS OF USE
|
|